Shire wins EMA blessing for Replagal plant
Shire has won European approval for its new manufacturing site in the U.S., allowing the U.K. company to ramp up production of its products, including Replagal for Fabry disease. Report
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Latest Commentary
EVENTS
- MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
- What's your BIO?June 18-21, 2012 — Boston, MA
Press Releases
- Orthofix International Completes Divestiture of Sports Medicine Business Unit
- ConforMIS iTotal CR Knee Replacement System Wins Silver in 2012 Medical Design Excellence Awards
- Health Canada Authorizes New Aurora Plasma Collection System from Fenwal Inc.
- Medtronic Resolute Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes
- Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay
- More Press Releases
Featured Jobs
-
Senior Manager, Clinical Data Management
TESARO - Waltham, MA -
Program Lead - Scientific Information Architecture & Search
Merck - Kenilworth, NJ -
Director, Safety Pharmacology and Toxicology
Tesaro - Waltham, MA -
Director, Human Resources
TESARO - Waltham, MA -
Supervisor, QC Chemistry - 3rd Shift Job
Celgene Corporation - Phoenix, AZ, US
Comments